RxDoctor Payments Data

Leah Ehle

Adult Health · Manchester, CTNPI 1407086036

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $326,376 of the $418,085 with a category attached, or 78.1%. Novartis accounts for 99.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $159,603 and has fallen 100.0% since, to $33 in 2025. Among adult health clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$418,085in general payments, 2019–2025

Across 70 payments — averaging $5972.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$417K
  • Johnson & Johnson$421
  • AbbVie$156
  • Bristol Myers Squibb$123
  • GSK$46

What the payments were for

  • Consulting fees$326,37678%
  • Speaking & faculty fees$5,9291%
  • Travel & lodging$85,03320%
  • Food & beverage$7470%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis55$417,338
Johnson & Johnson3$421
AbbVie8$156
Bristol Myers Squibb1$123
GSK3$46

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$418,085 in reported general payments places this provider in the 95th percentile of 418 adult health providers in Connecticut.

See all adult health providers in Connecticut →

Other adult health in Manchester

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →